2019 Publications
Jain Rahi and Rao Bakul (2019) “Role of laboratory services in primary health center (PHC) outpatient department performance: An Indian case study”, Primary Health Care Research & Development, 20 (e112), 1-7.
Jain Rahi, Rao Bakul and Mishra Satanand (2019) “Development of village system model for predicting and comparing the different interventions success”, Current Science, 117(7), 1189-1194.
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia.Puckrin R, Atenafu EG, Claudio JO, Chan S, Gupta V, Maze D, McNamara C, Murphy T, Shuh AC, Yee K, Sibai H, Minden MD, Wei C, Stockley T, Kamel-Reid S, Schimmer AD.Haematologica. 2020 Jan 2:haematol.2019.235721. doi: 10.3324/haematol.2019.235721.
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study. Khoja L, Atenafu EG, Suciu S, Leyvraz S, Sato T, Marshall E, Keilholz U, Zimmer L, Patel SP, Piperno-Neumann S, Piulats J, Kivelä TT, Pfoehler C, Bhatia S, Huppert P, Van Iersel LBJ, De Vries IJM, Penel N, Vogl T, Cheng T, Fiorentini G, Mouriaux F, Tarhini A, Patel PM, Carvajal R, Joshua AM.Ann Oncol. 2019 Aug 1;30(8):1370-1380.
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.Prem S, Atenafu EG, Avena J, Bautista R, Law A, Lam W, Michelis FV, Kim DDH, Viswabandya A, Lipton JH, Mattsson J, Kumar R.Eur J Haematol. 2019 Nov;103(5):483-490.
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.Hamilton RJ, Nayan M, Anson-Cartwright L, Atenafu EG, Bedard PL, Hansen A, Chung P, Warde P, Sweet J, O'Malley M, Sturgeon J, Jewett MAS.J Clin Oncol. 2019 Aug 1;37(22):1919-1926.
Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.Green BJ, Nguyen V, Atenafu E, Weeber P, Duong BTV, Thiagalingam P, Labib M, Mohamadi RM, Hansen AR, Joshua AM, Kelley SO.Anal Chem. 2019 Aug 6;91(15):9348-9355.
Kuehneet al. Characterization and outcomes of patients enrolled to multiple phase 1 cancer trials. Cancer Chemother Pharmacol. 2019 Nov 8. [Epub ahead of print]
Hansen et al. Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).Oncologist. 2019 Sep;24(9):1188-1194
Tanet al. Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era. Oncologist. 2019 Jul;24(7):e518-e525.
O'Kane et al. A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.Br J Cancer. 2019 Jun;120(12):1113-1119.
Planteet al. FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.Int J Gynecol Cancer. 2019 Jun;29(5):969-975.
Kanjanapan et al. Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities.Cancer. 2019 Apr 15;125(8):1341-1349.
Traverso, A., Kazmierski, M., Welch, M.L., Weiss, J.,Fiset, S., Foltz, W.D., Gladwish, A., Dekker, A., Jaffray, D., Wee, L. and Han, K., 2019. Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patients. Radiotherapy and Oncology.
Fiset, S., Welch, M.L., Weiss, J., Pintilie, M., Conway, J.L., Milosevic, M., Fyles, A., Traverso, A., Jaffray, D., Metser, U. and Xie, J., 2019. Repeatability and reproducibility of MRI-based radiomic features in cervical cancer. Radiotherapy and Oncology, 135, pp.107-114.
Espin-Garcia O, Croitoru K, Xu W. (2019). A finite mixture model for X-chromosomeassociation with an emphasis on microbiome data analysis. Genet Epidemiol. 43(4):427-439.doi: 10.1002/gepi.22190 [Highlighted as paper of the month in February 2019. https://twitter.com/genepisociety/status/1100017574631301122]
O'Kane GM, Liu G, Stockley TL, Shabir M, Zhang T, Law JH, Le LW, Sacher A, Shepherd FA, Bradbury PA, Leighl NB (2019). The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance. Lung Cancer131: 86-89.
Chen CI, Paul H, Le LW, Wei EN, Snitzler S, Wang T, Levina O, Kakar S, Lau A, Queau M, Johnston JB, Smith DA, Trudel S (2019). A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL). Leuk Lymphoma 60(1): 92-100
McCuaig JM, Tone AA, Maganti M, Romagnuolo T, Ricker N, Shuldiner J, Rodin G, Stockley T, Kim RH, Bernardini MQ.
Gynecol Oncol. 2019 Apr;153(1):108-115.
Masoomian M, Downes MR, Sweet J, Cheung C, Evans AJ, Fleshner N, Maganti M, Van der Kwast T.
Histopathology. 2019 Feb;74(3):474-482.
Yang D, Xu W. Statistical modeling on human microbiome sequencing data. Big Data and Information Analytics, 2019, 4(1): 1-12. doi: 10.3934/bdia.2019001. (SRA)
Ren J*, Xu W*, Su J, Ren X, Bender N, Habbous S, de Almeida JR, Goldstein DP, Cheng D, Chen Z, Mirshams M, Rahini M, Huang SH, Spreafico A, Hansen A, Kim J, Waldron J, Perez-Ordonez B, Zhao Y, Hung R, Waterboer T, Liu G. HPV Status Improves Classification of Head and Neck Gray Zone Cancers. J Dent Res. 2019 Jul;98(8):879-887. doi: 10.1177/0022034519853771. (PA)
Turpin W, Espin-Garcia O, Bedrani L, Madsen K, Meddings JB, Raygoza Garay JA, Silverberg MS, Smith MI, Griffiths AM, Moayyedi P, Marshall JK, Mack D, Seidman EG, Ropeleski M, Feagan BG, Jacobson K, Turner D, Walters T, Paterson AD; CCC GEM Project Research Consortium , Xu W*, Croitoru K*. Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. Inflamm Bowel Dis. 2019 Jun 28. pii: izz116. doi: 10.1093/ibd/izz116. [Epub ahead of print] (SRA)
Shepshelovich D*, Xu W*, Lu L, Fares A, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, Schwartz AG, Tardon A, Wu X, Schabath MB, Teare MD, Le Marchand L, Zhang ZF, Field JK, Brenner H, Daio N, Xie J, Kohno T, Harris CC, Wenzlaff AS, Fernandez-Tardon G, Ye Y, Taylor F, Wilkens LR, Davies M, Liu Y, Barnett MJ, Goodman GE, Morgenstern H, Holleczek B, Brown MC, Liu G, Hung R. Body mass index (BMI), BMI change, and overall survival in small cell and non-small cell lung cancer patients: a pooled analysis of the International Lung Cancer Consortium. J Thorac Oncol. 2019 Jun 1. pii: S1556-864(19)30416-2. (CO-PA)
Han D, Hao M, Qu L, Xu W. A Novel Model for the X-chromosome Inactivation Association on Survival Data. Statistical Methods in Medical Research. Stat Methods Med Res. 2019 Jun 30:962280219859037. doi: 10.1177/0962280219859037. [Epub ahead of print] (SRA)
Ren J*, Xu W*, Su J, Ren X, Cheng D, Chen Z, Bender N, Mirshams M, Habbous S, de Almeida JR, Perez-Ordonez B, Goldstein DP, Wang JR, Bratman SV, Huang SH, Jang R, Zhao Y, Waterboer T, Hung R, Liu G. Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable. Int J Cancer. 2019 Jul 3. doi: 10.1002/ijc.32548. [Epub ahead of print] (CO-PA)
Ren J, Yang W, Su J, Ren X, Fazelzad R, Albert T, Habbous S, Goldstein DP, de Almeida JR, Hansen A, Jang R, Bratman SV, Hope A, Chen R, Wang J, Xu Y, Cheng D, Zhao Y, Xu W*, Liu G*. Human Papillomavirus and p16 Immunostaining, Prevalence and Prognosis of Squamous Carcinoma of Unknown Primary in the Head and Neck Region. Int J Cancer. 2019 Jan 30. doi: 10.1002/ijc.32164. [Epub ahead of print] (SRA)
Espin-Garcia O, Croitoru K, Xu W. Afinite mixture model for X-chromosome association with an emphasis on microbiome data analysis. Genet Epidemiol. 2019 Jan 18. doi: 10.1002/gepi.22190. [Epub ahead of print]. (SRA)
Zhang J, Ye X, Wu C, Fu H, Xu W*, Hu P*. Modeling Gene-Environment Interaction for the Risk of Non-hodgkin Lymphoma. Front Oncol. 2019 Jan 14;8:657. (SRA)
Fatemeh Kamari Ghanavati, Alireza Choobineh, Sareh Keshavarzi, Ali Asghar Nasihatkon, Akram Sadat Jafari Roodbandi. (2019). Assessment of mental workload and its association with work ability in control room operators. MEDICINA DEL LAVORO. 110(5): 389-397.